| Primary |
| Drug Use For Unknown Indication |
37.5% |
| Nausea |
24.3% |
| Vomiting |
7.6% |
| Glioblastoma Multiforme |
4.2% |
| Hepatitis C |
4.2% |
| Migraine |
4.2% |
| Breast Cancer |
2.1% |
| Depression |
2.1% |
| Headache |
2.1% |
| Abdominal Pain |
1.4% |
| Abdominal Pain Upper |
1.4% |
| Bipolar Disorder |
1.4% |
| Cystitis |
1.4% |
| Hypersensitivity |
1.4% |
| Procedural Vomiting |
1.4% |
| Colon Cancer |
0.7% |
| Cyclic Vomiting Syndrome |
0.7% |
| Drug Hypersensitivity |
0.7% |
| Gastroenteritis |
0.7% |
| Gastrointestinal Obstruction |
0.7% |
|
| No Adverse Event |
9.5% |
| Tremor |
9.5% |
| Vomiting |
7.9% |
| Drug Ineffective |
6.3% |
| Swollen Tongue |
6.3% |
| Anxiety |
4.8% |
| Convulsion |
4.8% |
| Dystonia |
4.8% |
| Suicidal Ideation |
4.8% |
| Tongue Disorder |
4.8% |
| Trismus |
4.8% |
| Unevaluable Event |
4.8% |
| Vision Blurred |
4.8% |
| Cardiac Disorder |
3.2% |
| Completed Suicide |
3.2% |
| Hypersensitivity |
3.2% |
| Muscle Spasms |
3.2% |
| Respiratory Arrest |
3.2% |
| Somnolence |
3.2% |
| Tardive Dyskinesia |
3.2% |
|
| Secondary |
| Foetal Exposure During Pregnancy |
15.8% |
| Drug Use For Unknown Indication |
14.0% |
| Product Used For Unknown Indication |
13.1% |
| Nausea |
10.9% |
| Headache |
5.7% |
| Migraine |
4.1% |
| Vomiting |
4.1% |
| Depression |
3.6% |
| Asthma |
3.5% |
| Diabetes Mellitus |
3.2% |
| Oesophageal Carcinoma |
3.0% |
| Metastatic Malignant Melanoma |
2.5% |
| Breast Cancer |
2.4% |
| Pain |
2.4% |
| Smoking Cessation Therapy |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hypertension |
2.0% |
| Prophylaxis |
2.0% |
| Anxiety |
1.8% |
| Abdominal Discomfort |
1.7% |
|
| Drug Hypersensitivity |
33.3% |
| Vomiting |
18.7% |
| Weight Decreased |
6.4% |
| Stress |
5.8% |
| Tremor |
4.7% |
| Completed Suicide |
3.5% |
| Depression |
2.3% |
| Drug Ineffective |
2.3% |
| Poisoning |
2.3% |
| Somnolence |
2.3% |
| Urinary Tract Infection |
2.3% |
| Anaphylactic Reaction |
1.8% |
| Joint Stiffness |
1.8% |
| Nausea |
1.8% |
| Nervousness |
1.8% |
| Paraesthesia |
1.8% |
| Parkinson's Disease |
1.8% |
| Pneumonia |
1.8% |
| Rash |
1.8% |
| Tension Headache |
1.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.7% |
| Product Used For Unknown Indication |
15.5% |
| Nausea |
10.8% |
| Pain |
8.0% |
| Non-small Cell Lung Cancer |
5.8% |
| Multiple Myeloma |
5.4% |
| Breast Cancer |
4.8% |
| Hypertension |
4.4% |
| Vomiting |
3.3% |
| Prophylaxis |
3.1% |
| Anxiety |
2.6% |
| Breast Cancer Metastatic |
2.6% |
| Premedication |
2.4% |
| Constipation |
2.4% |
| Depression |
2.3% |
| Insomnia |
1.7% |
| Prostate Cancer |
1.6% |
| Colorectal Cancer Metastatic |
1.5% |
| Metastases To Bone |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
|
| Vomiting |
23.2% |
| Weight Decreased |
9.6% |
| White Blood Cell Count Decreased |
7.4% |
| Thrombocytopenia |
6.0% |
| Pyrexia |
5.7% |
| Pneumonia |
4.4% |
| Death |
4.3% |
| Urinary Tract Infection |
4.0% |
| Pulmonary Embolism |
3.4% |
| Nausea |
3.3% |
| Sepsis |
3.3% |
| Renal Failure Acute |
3.2% |
| Febrile Neutropenia |
3.1% |
| Neutropenia |
3.1% |
| Syncope |
2.8% |
| Weight Increased |
2.7% |
| Pleural Effusion |
2.6% |
| Rash |
2.6% |
| Renal Failure |
2.6% |
| Dehydration |
2.5% |
|
| Interacting |
| Adenocarcinoma Pancreas |
31.6% |
| Nausea |
21.1% |
| Malignant Soft Tissue Neoplasm |
15.8% |
| Pain |
15.8% |
| Back Pain |
5.3% |
| Non-small Cell Lung Cancer |
5.3% |
| Sleep Disorder |
5.3% |
|
| Upper Gastrointestinal Haemorrhage |
25.0% |
| Vision Blurred |
25.0% |
| Pharmaceutical Product Complaint |
12.5% |
| Rash |
12.5% |
| Somnolence |
12.5% |
| Vomiting |
12.5% |
|
